… drug amount through human milk. As population-based evidence is still scarce on safety
of drugs during breastfeeding, risk assessment relies on the little clinical evidence available …

… evidence for their effects secondary to pregnancy exposure is extremely limited. While this
review does not identify clear evidence for a risk of malformation, there is evidence … maternal …

… There is evidence of an increase in the prevalence of diabetes among women of childbearing
age … In this context, it is critical to establish the safety of hypoglycemic drugs, both during …

… up-to-date, evidence-based information regarding the safety of antipsychotic drugs that are
… maternal treatment. In rats, a decrease in fetal weight and delayed ossification was seen at …

… evidence available in current research, there is a strong suggestion that fetal development
is affected by prenatal maternal … To date, there is no definitive evidence demonstrating safe …

… maternal disease leads to low birthweight and in the presence of maternal disease substantially
increases the risk of maternal … such drugs, although there has been no human evidence …

… studies for drug safety in pregnancy and randomized controlled trials for drug effectiveness
for nausea and vomiting in pregnancy. Results: All of the following are safe and effective for …

… safety outcomes in infants/children exposed to AEDs in utero or during breast feeding in one
publication, but given the breadth of evidence … The mean maternal age ranged from 24 to 34 …

… of drug in the foetal or maternal circulation, and as maternal … , the maternal-to-foetal ratio of
total drug plasma concentration … In the absence of conclusive evidence from DAA exposure …

… accelerated metabolism of it and other drugs owing to the induction of key drug-metabolizing
enzymes. Citation252 There is not yet clear evidence that administering vitamin K analogs …